Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Mereo BioPharma Group plc MREO

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:MREO)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

ACCESS Newswire 1 day ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

GlobeNewswire 2 days ago

MREO Investor Notice: Levi & Korsinsky Investigates Mereo BioPharma Group plc for Securities Law Violations

Newsfile 4 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

ACCESS Newswire 4 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

ACCESS Newswire 5 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mereo BioPharma Group plc (MREO) and Encourages Shareholders to Learn More About the Investigation

ACCESS Newswire 6 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

ACCESS Newswire 6 days ago

Mereo BioPharma Group plc (MREO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

ACCESS Newswire 7 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Mereo BioPharma Group plc (MREO) Shareholders to Inquire about Securities Investigation

ACCESS Newswire 8 days ago

Opinion & Analysis (NDAQ:MREO)

No current opinion is available.

Bullboard Posts (NDAQ:MREO)

Buy buddy buy.

Hey you guys out there,this will be your last chance to get on board with this stock already and it's at a big bargain price,before...
coolfooldumbguy - 7 days ago

This stock is a good buy for me at a bargain price.

It is more than a triple in price per share for me since the end of last year,thank you guys.
coolfooldumbguy - 9 days ago

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway,so good luck to all of you guys
coolfooldumbguy - 10 days ago

Using technical analysis for this stock.

Bought this stock at less than a quarter per share last week on Monday morning and it has been a big double for me already.Well,it should...
coolfooldumbguy - January 5, 2026